Patent ID: 11912715
Assignee: NOVARTIS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 20:
21. A method of treating a viral infection, comprising administering to a subject a therapeutically effective amount of a compound of the formula:, wherein Y represents a group selected from, wherein
Z1 is N or CH,
Z3 is CH2, Q, —CH2—CH2—, -Q-CH2—, —CH2-Q-, —CH2-Q-CH2— or —CH2—CH2—CH2—;
Q is selected from —NR—, O, S, SO, and SO2;
each R3 is a substituent optionally present on any carbon atom of the ring containing Z3, and is independently selected from halo, —OR, C1-4 haloalkyl, C1-4 haloalkoxy, oxo, CN, —NR2, and C1-4 alkyl optionally substituted with up to three groups independently selected from halo, CN, C1-4 alkyl, —OR, C1-4 haloalkoxy, —NR2, and C1-4 haloalkyl;
n is 0-2;
each Ry is independently selected from halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, C2-4 alkyne, and CN;
each R is independently at each occurrence H or C1-4 alkyl optionally substituted with up to three groups independently selected from halo, OH, oxo, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkoxy, and C1-4 haloalkyl; and
each q is independently 0, 1 or 2.